Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CD38 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	daratumumab Sensitive: B - Late Trials daratumumab Sensitive : B	daratumumab Sensitive: B - Late Trials daratumumab Sensitive : B
CD38 expression	Lymphoma	CD38 expression	Lymphoma	rituximab + NKTR-255 Sensitive: C3 – Early Trials rituximab + NKTR-255 Sensitive : C3	rituximab + NKTR-255 Sensitive: C3 – Early Trials rituximab + NKTR-255 Sensitive : C3
CD38 expression	Waldenstrom Macroglobulinemia	CD38 expression	Waldenstrom Macroglobulinemia	daratumumab Sensitive: C3 – Early Trials daratumumab Sensitive : C3	daratumumab Sensitive: C3 – Early Trials daratumumab Sensitive : C3
CD38 expression	Lymphoma	CD38 expression	Lymphoma	daratumumab + NKTR-255 Sensitive: C3 – Early Trials daratumumab + NKTR-255 Sensitive : C3	daratumumab + NKTR-255 Sensitive: C3 – Early Trials daratumumab + NKTR-255 Sensitive : C3
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	BHV-1100 Sensitive: C3 – Early Trials BHV-1100 Sensitive : C3	BHV-1100 Sensitive: C3 – Early Trials BHV-1100 Sensitive : C3
CD38 expression	Triple Negative Breast Cancer	CD38 expression	Triple Negative Breast Cancer	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3	durvalumab Sensitive: C3 – Early Trials durvalumab Sensitive : C3
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	STI-6129 Sensitive: D – Preclinical STI-6129 Sensitive : D	STI-6129 Sensitive: D – Preclinical STI-6129 Sensitive : D
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	SAR442257 Sensitive: D – Preclinical SAR442257 Sensitive : D	SAR442257 Sensitive: D – Preclinical SAR442257 Sensitive : D
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	SAR442085 Sensitive: D – Preclinical SAR442085 Sensitive : D	SAR442085 Sensitive: D – Preclinical SAR442085 Sensitive : D
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	TAK-079 Sensitive: D – Preclinical TAK-079 Sensitive : D	TAK-079 Sensitive: D – Preclinical TAK-079 Sensitive : D
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	ISB 1342 Sensitive: D – Preclinical ISB 1342 Sensitive : D	ISB 1342 Sensitive: D – Preclinical ISB 1342 Sensitive : D
CD38 expression	B Acute Lymphoblastic Leukemia	CD38 expression	B Acute Lymphoblastic Leukemia	isatuximab-irfc Sensitive: D – Preclinical isatuximab-irfc Sensitive : D	isatuximab-irfc Sensitive: D – Preclinical isatuximab-irfc Sensitive : D
CD38 expression	T Acute Lymphoblastic Leukemia	CD38 expression	T Acute Lymphoblastic Leukemia	isatuximab-irfc Sensitive: D – Preclinical isatuximab-irfc Sensitive : D	isatuximab-irfc Sensitive: D – Preclinical isatuximab-irfc Sensitive : D
CD38 expression	Multiple Myeloma	CD38 expression	Multiple Myeloma	MT-0169 Sensitive: D – Preclinical MT-0169 Sensitive : D	MT-0169 Sensitive: D – Preclinical MT-0169 Sensitive : D
CD38 expression	Peripheral T-cell Lymphoma	CD38 expression	Peripheral T-cell Lymphoma	SAR442257 Sensitive: D – Preclinical SAR442257 Sensitive : D	SAR442257 Sensitive: D – Preclinical SAR442257 Sensitive : D